Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
4 clinical trials · Condition
◉ Watch Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
| Record | Firm | Date |
|---|---|---|
| Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System (NCT05211336) | National Cancer Institute (NCI) | 2022-04-19 |
| Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672) | National Cancer Institute (NCI) | 2018-12-21 |
| Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma (NCT01722305) | Mayo Clinic | 2013-04-08 |
Track Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS) automatically
Every clearance here is in the API, with alerts when new ones post.